RNA editing

FDA Clears Ascidian for First-Ever RNA Editing Trial in US
BioSpace
Tue, 01/30/24 - 09:22 pm
Ascidian Therapeutics
FDA
clinical trials
Stargardt disease
RNA editing
Interest in RNA Editing Accelerates as Therapies Approach the Clinic
BioSpace
Wed, 10/18/23 - 11:37 am
RNA editing
Alnylam
Shape Therapeutics
Eli Lilly
ProQR Therapeutics
First RNA Editing Therapy Nears Clinic as Excitement Mounts
BioSpace
Mon, 10/9/23 - 10:21 am
Wave Life Sciences
WVE-006
RNA editing
alpha-1 antitrypsin deficiency
Startup AIRNA emerges from stealth to bring RNA editing to a rare disease
BioPharma Dive
Tue, 09/19/23 - 10:51 am
AIRNA
startups
RNA editing
funding
Otsuka, Shape Ink Potential $1.5B Deal to Develop Eye AAV Gene Therapies
BioSpace
Fri, 09/8/23 - 10:11 am
Otsuka
Shape Therapeutics
gene therapy
AAV gene therapy
RNA editing
ocular diseases
Wave readies clinical testing for first RNA editing therapy
BioPharma Dive
Tue, 09/5/23 - 08:40 pm
Wave Life Sciences
RNA editing
Just months after layoffs and pushing eye therapy, ProQR offloads eye portfolio in pivot to RNA-editing
Endpoints
Thu, 08/11/22 - 12:05 pm
ProQR Therapeutics
RNA editing
Mega $3 Billion+ Deal Shapes Up for Roche to Target AD and Parkinson's
BioSpace
Tue, 08/24/21 - 11:12 am
Roche
Shape Therapeutics
RNA editing
RNAfix
Alzheimer's disease
Parkinson's Disease